Superficial femoral artery (SFA)

Lodha
Video
The NEW 2.00 Max Crown in Long SFA Lesion
04/06/2023
Dr. Lodha, an interventional cardiologist, takes a radial approach and safely treats moderately calcified lesions in the SFA and popliteal arteries.
Dr. Lodha, an interventional cardiologist, takes a radial approach and safely treats moderately calcified lesions in the SFA and popliteal arteries.
Dr. Lodha, an interventional...
04/06/2023
Vascular Disease Management
Original Contribution
Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?
06/01/2022
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct...
06/01/2022
Journal of Invasive Cardiology
Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions
Calcium Corner
Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions
01/01/2020
The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.
The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.
The Eluvia stent utilizes a...
01/01/2020
Cath Lab Digest
Case Report
Interventional Therapy of Complex Superficial Femoral Artery Disease Via Femoral-Femoral Crossover Graft
07/31/2019
This case adds insight into the benefit of complementary endovascular technologies with difficult vascular surgery to improve outcomes in complex peripheral vascular disease.
This case adds insight into the benefit of complementary endovascular technologies with difficult vascular surgery to improve outcomes in complex peripheral vascular disease.
This case adds insight into the...
07/31/2019
Cath Lab Digest
Case Report
Optimizing Success in Treating Occlusive Disease of the Superficial Femoral Artery
12/07/2015
The superficial femoral artery (SFA) is unlike any other vessel in the body and presents unique challenges for endovascular intervention. Complete occlusions tend to predominate stenosis, and disease is often diffuse along the SFA. 
The superficial femoral artery (SFA) is unlike any other vessel in the body and presents unique challenges for endovascular intervention. Complete occlusions tend to predominate stenosis, and disease is often diffuse along the SFA. 
The superficial femoral artery...
12/07/2015
Cath Lab Digest
Case Report
Revascularization of Superficial Femoral Artery Chronic Total Occlusion
03/30/2012
Emerging technologies constantly redefine the clinical landscape in the treatment of PAD We describe a case utilizing the adjunctive therapy of the Wildcat catheter with the motorized Juicebox console (Avinger, Inc.) in crossing a complex...
Emerging technologies constantly redefine the clinical landscape in the treatment of PAD We describe a case utilizing the adjunctive therapy of the Wildcat catheter with the motorized Juicebox console (Avinger, Inc.) in crossing a complex...
Emerging technologies constantly...
03/30/2012
Vascular Disease Management
Original Research
Initial Experience in the Treatment of Chronic Superficial Femoral Artery Occlusion with Fiberoptic Guidance Technology
09/05/2008
Percutaneous treatment of chronic total occlusions may result in dissection or perforation. A fiberoptic guidance system that visualizes lesion characteristics and incorporates a radiofrequency energy source to aid in crossing total...
Percutaneous treatment of chronic total occlusions may result in dissection or perforation. A fiberoptic guidance system that visualizes lesion characteristics and incorporates a radiofrequency energy source to aid in crossing total...
Percutaneous treatment of...
09/05/2008
Vascular Disease Management

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use